cacy of this very drug. While the medication was shown to decrease the rate of relapses, it had “little or no effect on a patient’s progression to disability.” As someone with only minimal symptoms, I read this as a validation of my decision to quit. If I am feeling well, why lose two days out of each week if the medication won’t even help ward off disability? I felt triumphant, with both science and intuition on my side. Still, it took me weeks to tell my neurologist that I was no longer taking the medication."